<DOC>
	<DOCNO>NCT01910376</DOCNO>
	<brief_summary>Cancer disease elderly . Cancer incidence 11-fold high person age 65 , young one . Approximately 60 % cancer 70 % cancer mortality occur people old 65 year . Moreover , due age population Western world number elderly people expect increase therefore number old cancer patient expect rise . Despite rapid increase cancer incidence cancer-related mortality age , knowledge age cancer optimal treatment old cancer patient still far adequate . Therefore , clear cancer elderly major increase health problem . A key problem geriatric oncology research important selection bias old/frail patient , rarely include clinical trial . Changes pattern health care delivery shift care elderly acute care setting community long-term care facility . As European population age , people become nursing home resident , many suspicion , diagnose , eventually die , cancer . Although cancer common elderly nursing home resident , poorly study . This lack information may impact clinical decision make appropriateness treatment offer therefore collection information need . This project two main objective . The first objective report demographic , referral pattern motif non-referral , anti-cancer treatment outcome patient nurse home suspect diagnosed active invasive cancer diagnostic treatment decision take . The second objective develop well prognostic tool ( survival ) include biological marker age help treatment decision elderly .</brief_summary>
	<brief_title>Cancer Nursing Home Residents</brief_title>
	<detailed_description />
	<criteria>All individual : Age ≥ 65 year Residents nursing home Armonea network Belgium . Absence psychological , familial , sociological condition potentially hamper compliance study protocol ; condition discuss patient/proxy registration study . Written informed consent must give accord ICH/GCP , national/local regulation . The treat general practitioner ( GP ) willing provide medical information require study . Cancer patient cohort : Patients must new cancer event define one : A strong clinical suspicion ( base physician 's judgement ) new cancer diagnostic therapeutic decision need take . A strong clinical suspicion ( base physician 's judgement ) progression previously know cancer diagnostic therapeutic decision need take . Diagnosis new cancer diagnostic therapeutic decision need take . Diagnosis progression previously know cancer diagnostic therapeutic decision need take . All invasive cancer type histology eligible . All line treatment eligible . Patients diagnose cancer routine medical examination medical condition Control cohort : • Absence know active invasive cancer , strong clinical suspicion cancer ( base physician 's judgement ) baseline . Exclusion criterion : Patients suspect cancer ( progression ) nursing home , hospitalize ( medical ) reason , diagnose cancer hospitalization .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>